Observational studies on macroprolactin in a routine clinical laboratory

It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. A retrospective study of macroprolactin wa...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 56; no. 8; pp. 1259 - 1262
Main Authors Barth, Julian H., Lippiatt, Carys M., Gibbons, Stephen G., Desborough, Robert A.
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 26.07.2018
Walter De Gruyter & Company
Subjects
Online AccessGet full text
ISSN1434-6621
1437-4331
1437-4331
DOI10.1515/cclm-2018-0074

Cover

Abstract It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation. The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])). The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.
AbstractList It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. Methods: A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation. Results: The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])). Conclusions: The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.
It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation. The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])). The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.
It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin.BACKGROUNDIt is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin.A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation.METHODSA retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation.The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])).RESULTSThe incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])).The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.CONCLUSIONSThe presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.
Author Desborough, Robert A.
Lippiatt, Carys M.
Gibbons, Stephen G.
Barth, Julian H.
Author_xml – sequence: 1
  givenname: Julian H.
  surname: Barth
  fullname: Barth, Julian H.
  email: julian.barth@nhs.net
  organization: Blood Sciences, Leeds General Infirmary, Leeds LS 3EX, UK, Phone: 0113 392 2584, Fax: 0113 392 5174
– sequence: 2
  givenname: Carys M.
  surname: Lippiatt
  fullname: Lippiatt, Carys M.
  organization: Blood Sciences, Leeds General Infirmary, Leeds, UK
– sequence: 3
  givenname: Stephen G.
  surname: Gibbons
  fullname: Gibbons, Stephen G.
  organization: Blood Sciences, Leeds General Infirmary, Leeds, UK
– sequence: 4
  givenname: Robert A.
  surname: Desborough
  fullname: Desborough, Robert A.
  organization: Blood Sciences, Leeds General Infirmary, Leeds, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29630507$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1r3DAQxUVJaZJtrzkGQy65eKtvWYceQkiaQiCX5GxkeVy0yNZWkhP2v4-cTVtYWhDMO_yemHnvFB1NYQKEzgheE0HEV2v9WFNMmhpjxT-gE8KZqjlj5OhN81pKSo7RaUobjIkQXH1Cx1RLhgVWJ-juoUsQn012YTK-SnnuHaQqTNVobAzbGLyx2U1VeaaKYS4aKuvd5GzhvelCNDnE3Wf0cTA-wZf3uUJPtzeP13f1_cP3H9dX97XlVOSa9xR0A_3QKCU6qbkauDbadkrqZhh6rjtQPeOKSCCsLMkYl8Ckkr3h2ABbocv9v2W1XzOk3I4uWfDeTBDm1FJMmWJclAtX6OIA3YQ5ljMXSipNBMW4UOfv1NyN0Lfb6EYTd-3vjAqw3gMlj5QiDH8QgtulhHYpoV1KaJcSioEfGKzLbwnnaJz_v-3b3vZifIbYw88474r4u_W_jUI2hArNXgGeKp5o
CitedBy_id crossref_primary_10_1016_j_ando_2024_101677
crossref_primary_10_1515_almed_2024_0010
crossref_primary_10_1515_almed_2024_0098
crossref_primary_10_3343_alm_2022_42_1_3
crossref_primary_10_1093_labmed_lmac136
crossref_primary_10_1186_s12902_021_00861_z
crossref_primary_10_1515_cclm_2020_0858
crossref_primary_10_1055_a_0902_4439
crossref_primary_10_3390_metabo15010009
crossref_primary_10_3390_ijerph17218199
crossref_primary_10_1016_j_cca_2023_117358
crossref_primary_10_1515_cclm_2019_0898
crossref_primary_10_1111_cen_15051
Cites_doi 10.1258/000456302760042128
10.3109/09513590.2014.887672
10.1210/jc.2010-0114
10.1530/EJE-14-1073
10.1093/clinchem/46.6.884
10.1210/jc.2004-2234
10.1373/49.9.1504
10.1111/j.1365-2265.2009.03570.x
10.1210/jc.2001-011943
10.1093/clinchem/47.2.331
10.1530/EJE-11-1007
10.1258/acb.2009.009059
ContentType Journal Article
Copyright Copyright Walter De Gruyter & Company 2018
Copyright_xml – notice: Copyright Walter De Gruyter & Company 2018
DBID AAYXX
CITATION
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1515/cclm-2018-0074
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Biotechnology Research Abstracts
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 1262
ExternalDocumentID 29630507
10_1515_cclm_2018_0074
10_1515_cclm_2018_00745681259
Genre Journal Article
GroupedDBID ---
0R~
0~D
29B
354
36B
4.4
53G
5GY
5RE
AAAEU
AABBZ
AAFPC
AAGVJ
AAILP
AALGR
AAONY
AAOQK
AAOWA
AAPJK
AAQCX
AARRE
AASQH
AAWFC
AAXCG
ABAOT
ABAQN
ABDRH
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABRQL
ABUVI
ABWLS
ABXMZ
ABYBW
ACDEB
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACUND
ACXLN
ACYCL
ACZBO
ADDWE
ADEQT
ADGQD
ADGYE
ADNPR
ADOZN
AECWL
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFBAA
AFBDD
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AHOVO
AHVWV
AHXUK
AIERV
AIKXB
AIWOI
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
AMAVY
ASYPN
AZMOX
BAKPI
BBCWN
BCIFA
BWHEM
CGQUA
CS3
DSRVY
DU5
EBS
EJD
EMOBN
F5P
FSTRU
HZ~
IY9
KDIRW
N9A
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
AAYXX
CITATION
ABVMU
ALYBR
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c425t-4d2e98edf8775b6947f49a9cb7698ffd49be7d34716e133053346e3676da40ae3
ISSN 1434-6621
1437-4331
IngestDate Mon Sep 29 05:34:57 EDT 2025
Mon Jun 30 14:55:53 EDT 2025
Thu Apr 03 07:05:19 EDT 2025
Wed Oct 01 03:28:51 EDT 2025
Thu Apr 24 23:09:05 EDT 2025
Sat Sep 06 17:01:56 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords polyethyelene glycol
macroprolactin
prolactin
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c425t-4d2e98edf8775b6947f49a9cb7698ffd49be7d34716e133053346e3676da40ae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 29630507
PQID 2067915200
PQPubID 105421
PageCount 4
ParticipantIDs proquest_miscellaneous_2023734596
proquest_journals_2067915200
pubmed_primary_29630507
crossref_primary_10_1515_cclm_2018_0074
crossref_citationtrail_10_1515_cclm_2018_0074
walterdegruyter_journals_10_1515_cclm_2018_00745681259
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-07-26
PublicationDateYYYYMMDD 2018-07-26
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-26
  day: 26
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2018
Publisher De Gruyter
Walter De Gruyter & Company
Publisher_xml – name: De Gruyter
– name: Walter De Gruyter & Company
References (ref171) 2016; 54
(ref71) 2003; 49
(ref31) 2014; 30
(ref41) 2013; 34
(ref51) 2010; 95
(ref141) 2001; 47
(ref151) 2009; 71
(ref61) 2012; 166
(ref251) 2009; 46
(ref91) 2002; 87
(ref311) 2001; 47
(ref301) 2005; 90
(ref231) 2012; 166
(ref21) 2016; 54
(ref161) 2002; 39
(ref281) 2017; 55
(ref271) 2016; 20
(ref121) 2015; 172
(ref191) 2016; 54
(ref101) 2016; 20
(ref201) 2014; 30
(ref111) 2017; 55
(ref331) 2002; 39
(ref131) 2005; 90
(ref221) 2010; 95
(ref241) 2003; 49
(ref211) 2013; 34
(ref291) 2015; 172
(ref01) 2016; 54
(ref321) 2009; 71
(ref11) 2000; 46
(ref81) 2009; 46
(ref261) 2002; 87
(ref181) 2000; 46
References_xml – volume: 54
  start-page: 519
  year: 2016
  ident: ref01
  article-title: Macroprolactin: searching for a needle in a haystack?
  publication-title: Clin Chem Lab Med
– volume: 39
  start-page: 366
  year: 2002
  ident: ref161
  article-title: Interference in immunoassay is an underestimated problem
  publication-title: Ann Clin Biochem
  doi: 10.1258/000456302760042128
– volume: 30
  start-page: 385
  year: 2014
  ident: ref201
  article-title: Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2014.887672
– volume: 34
  start-page: 207
  year: 2013
  ident: ref211
  article-title: Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up
  publication-title: Neuro Endocrinol Lett
– volume: 39
  start-page: 366
  year: 2002
  ident: ref331
  article-title: Interference in immunoassay is an underestimated problem
  publication-title: Ann Clin Biochem
  doi: 10.1258/000456302760042128
– volume: 34
  start-page: 207
  year: 2013
  ident: ref41
  article-title: Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up
  publication-title: Neuro Endocrinol Lett
– volume: 30
  start-page: 385
  year: 2014
  ident: ref31
  article-title: Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2014.887672
– volume: 95
  start-page: 3268
  year: 2010
  ident: ref51
  article-title: Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0114
– volume: 55
  start-page: 1744
  year: 2017
  ident: ref281
  article-title: Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: 1744
  year: 2017
  ident: ref111
  article-title: Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia
  publication-title: Clin Chem Lab Med
– volume: 54
  start-page: 519
  year: 2016
  ident: ref171
  article-title: Macroprolactin: searching for a needle in a haystack?
  publication-title: Clin Chem Lab Med
– volume: 172
  start-page: 687
  year: 2015
  ident: ref291
  article-title: Macroprolactinoma: a biological diagnostic strategy from the study of 222 patients
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-14-1073
– volume: 46
  start-page: 884
  year: 2000
  ident: ref181
  article-title: Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers
  publication-title: Clin Chem
  doi: 10.1093/clinchem/46.6.884
– volume: 54
  start-page: 603
  year: 2016
  ident: ref191
  article-title: A possible cause of the variable detectability of macroprolactin by different immunoassay systems
  publication-title: Clin Chem Lab Med
– volume: 90
  start-page: 3927
  year: 2005
  ident: ref131
  article-title: The impact on clinical practice of routine screening for macroprolactin
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-2234
– volume: 49
  start-page: 1504
  year: 2003
  ident: ref241
  article-title: Frequent Misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia
  publication-title: Clin Chem
  doi: 10.1373/49.9.1504
– volume: 20
  start-page: 1788
  year: 2016
  ident: ref271
  article-title: A new criteria for screening macroprolactinaemia using polyethylene glycol treatment combined with different assays for prolactin
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 71
  start-page: 702
  year: 2009
  ident: ref151
  article-title: Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2009.03570.x
– volume: 87
  start-page: 5410
  year: 2002
  ident: ref261
  article-title: Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2001-011943
– volume: 172
  start-page: 687
  year: 2015
  ident: ref121
  article-title: Macroprolactinoma: a biological diagnostic strategy from the study of 222 patients
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-14-1073
– volume: 46
  start-page: 884
  year: 2000
  ident: ref11
  article-title: Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers
  publication-title: Clin Chem
  doi: 10.1093/clinchem/46.6.884
– volume: 90
  start-page: 3927
  year: 2005
  ident: ref301
  article-title: The impact on clinical practice of routine screening for macroprolactin
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-2234
– volume: 71
  start-page: 702
  year: 2009
  ident: ref321
  article-title: Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2009.03570.x
– volume: 20
  start-page: 1788
  year: 2016
  ident: ref101
  article-title: A new criteria for screening macroprolactinaemia using polyethylene glycol treatment combined with different assays for prolactin
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 49
  start-page: 1504
  year: 2003
  ident: ref71
  article-title: Frequent Misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia
  publication-title: Clin Chem
  doi: 10.1373/49.9.1504
– volume: 47
  start-page: 331
  year: 2001
  ident: ref141
  article-title: Prolactin results for samples containing macroprolactin are method and sample dependent
  publication-title: Clin Chem
  doi: 10.1093/clinchem/47.2.331
– volume: 87
  start-page: 5410
  year: 2002
  ident: ref91
  article-title: Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2001-011943
– volume: 54
  start-page: 603
  year: 2016
  ident: ref21
  article-title: A possible cause of the variable detectability of macroprolactin by different immunoassay systems
  publication-title: Clin Chem Lab Med
– volume: 166
  start-page: 625
  year: 2012
  ident: ref231
  article-title: The natural history of macroprolactinaemia
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-11-1007
– volume: 47
  start-page: 331
  year: 2001
  ident: ref311
  article-title: Prolactin results for samples containing macroprolactin are method and sample dependent
  publication-title: Clin Chem
  doi: 10.1093/clinchem/47.2.331
– volume: 46
  start-page: 501
  year: 2009
  ident: ref251
  article-title: Macroprolactin on the Advia Centaur – experience with 409 patients over a 3 year period
  publication-title: Ann Clin Biochem
  doi: 10.1258/acb.2009.009059
– volume: 95
  start-page: 3268
  year: 2010
  ident: ref221
  article-title: Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0114
– volume: 166
  start-page: 625
  year: 2012
  ident: ref61
  article-title: The natural history of macroprolactinaemia
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-11-1007
– volume: 46
  start-page: 501
  year: 2009
  ident: ref81
  article-title: Macroprolactin on the Advia Centaur – experience with 409 patients over a 3 year period
  publication-title: Ann Clin Biochem
  doi: 10.1258/acb.2009.009059
SSID ssj0015547
Score 2.3014128
Snippet It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our...
SourceID proquest
pubmed
crossref
walterdegruyter
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1259
SubjectTerms Incidence
Laboratories
macroprolactin
Observational studies
polyethyelene glycol
Polyethylene glycol
Prolactin
Reproducibility
Title Observational studies on macroprolactin in a routine clinical laboratory
URI https://www.degruyter.com/doi/10.1515/cclm-2018-0074
https://www.ncbi.nlm.nih.gov/pubmed/29630507
https://www.proquest.com/docview/2067915200
https://www.proquest.com/docview/2023734596
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAZK
  databaseName: De Gruyter Complete Journal Package 2023
  customDbUrl:
  eissn: 1437-4331
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015547
  issn: 1434-6621
  databaseCode: AGBEV
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.degruyterbrill.com
  providerName: Walter de Gruyter
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0CqdBONhgvEVGChICB6QoUlsJ34cVbcK7eOlRX2LbMdBSFuydalQ-fWcHSdpWJEGUhVVjpWzfOfzfR9C72SY6ZwkGaZKK0yAhrCEixDD3R3EMRV0FJh859MzNp2Trwu6GAzWG1FLq0p-Ur-25pX8D1ZhDPBqsmT_AbPtR2EA_gN-4QkYhuedcHwuW5uqTfuwIYHG_H8pTGeuJaitwM5sLKP4uCxhJSBStrmQDv9lPyl63LxWTSs461_oJt92xwsXZWhyrYFdtM4nW_xBVE1gyfqmM70e_5CyrEV4F2fWNfkCVRhgme5BXei3M7k680SQGLtnnQPvOCqJ4i4tS28Zc2yYsg1ySzZ4KohgfCuzp7YuhlIXl7iGPKob_vSrap-dp0fzk5N0NlnM3l9dY9NwzDjmXfeVe2gnjBkLh2jn8PjL5FvrggI5y3bmadbqKn4C0M99kH2J5paa8hDt_bSRD5n-vlytq8bTbgWY2SO05zQP_7Amo8dooIt99GDcYHkf3T91iH2Cpj3K8h1l-WXh9ynLh5_wHWX5DWX5HbE8RfOjyWw8xa7nBlbAvStMslDzRGd5AidVMk7inHDBlYwZT_I8I1zqOItApGE6iCKbyc20KfuXCTISOnqGhkVZ6BfIjxnJeQLyTk4FiEqx5ExSlSnBMtASGPEQbvYtVa4gvemLcpEaxRT2OTX7nJp9Ts0-e-hDO_-qLsXy15kHDRpSd1xvUtOngAemypiH3ravYYuNh0wUulyZOWEUR4Ry5qHnNfpaUCFcVSPQnjzE_sBnB2P7cmyNP8pf3gHsK7TbHaIDNKyWK_0apN5KvnH0-Rv1gLB5
linkProvider Walter de Gruyter
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7RRSrtASiFNkBpKlXqyewmcez4CAi6bVl6gYpb5FdAYjepQqKK_vqONw-evbRSbrHjeGbsb_yYbwA-qtDYjCaGxNpqQtGGiEIgJIjdAeexjEeBi3eenLDxGf16Hp_fiYVx1yqNvSjrm6phSB2aQtduo6znGkAEHmo9naGCg4Q4DBxeVrPpM1jExQqjA1jc-7x_-KM_S0DAnKdYoREljIVBS934-DP3oemRv_kSln_Nj7D7_7uDREcroLs-NBdQrnbrSu3q3w_oHf-vk6uw3Dqq_l5jWa9gweZrsHTQ5Ydbg-eT9lj-NYy_q35zF-tcN3cT_SL3Z9KlCCtx_Yzzau7jI_2yQGPPrd8FZfqtIRblzTqcHR2eHoxJm6KBaBzsFaEmtCKxJktQsYoJyjMqpNCKM5FkmaFCWW4iREBmcTU8D_xl1rHEGUlH0kYbMMiL3L4FnzOaiQThMYslIitXgqlYGy2ZQaeSUQ9Ip51Ut_zlLo3GNHXrGJRX6uSVOnmlTl4efOrL_2yYO_5acrtTdtqO4OvU0dqLwJFSefChf40idgcqMrdF7cqEEY9oLJgHbxoj6ZsKcWYbobPtAXtgNbdtPP07c0q4WGz-a8X3sDQ-nRynx19Ovm3Bi8aAOAnZNgyqsrbv0Iuq1E47TP4A1b0XHg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BKxU4tKUUSFtKkJA4ubtJHDs-9rVsCy0cKOIW-RUOtEmVTYTKr2e8cdIXXEDKLXYcz4z9je3xNwBvVWxsQTNDUm01oWhDRCEQEsTuiPNUpuPI3Xc-OWXTM3r8Le2jCWc-rNLY73V71XQMqSNT6dZtlA1cA4jAI63PL1DBUUYcBo4uTfEQFhHrM1x_Le6-3zv8OhwlIF7OM6zQhBLG4sgzN97_ym1kuuduPoHln_MT7OH3bgDRZAVU34Uu_uTHTtuoHf3rDrvjf_VxFZa9mxrudnb1FB7Ycg0e7ffZ4dZg6cQfyj-D6Sc1bO1inVkXmRhWZXghXYKwGlfPOKuWIT4yrCs09dKG_ZXM0JthVV-tw9nk8Mv-lPgEDUTjUG8INbEVmTVFhmpVTFBeUCGFVpyJrCgMFcpykyD-MYtr4fm1X2YdR5yRdCxt8hwWyqq0LyHkjBYiQ3AsUom4ypVgKtVGS2bQpWQ0ANIrJ9eevdwl0TjP3SoGxZU7ceVOXLkTVwDvhvKXHW_HX0tu9brO_fid5Y7UXkSOkiqAN8NrFLE7TpGlrVpXJk54QlPBAnjR2cjQVIzz2hhd7QDYHaO5buPPvzMnhEvFxr9WfA1Lnw8m-cej0w-b8LgzH05itgULTd3aV-hCNWrbD5LfsCsV1w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Observational+studies+on+macroprolactin+in+a+routine+clinical+laboratory&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Barth%2C+Julian+H&rft.au=Lippiatt%2C+Carys+M&rft.au=Gibbons%2C+Stephen+G&rft.au=Desborough%2C+Robert+A&rft.date=2018-07-26&rft.issn=1437-4331&rft.eissn=1437-4331&rft.volume=56&rft.issue=8&rft.spage=1259&rft_id=info:doi/10.1515%2Fcclm-2018-0074&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon